John DeFord - Sep 1, 2023 Form 4/A - Amendment Insider Report for GLOBUS MEDICAL INC (GMED)

Role
Director
Signature
/s/ Kelly G. Huller, Attorney-in-Fact
Stock symbol
GMED
Transactions as of
Sep 1, 2023
Transactions value $
$0
Form type
4/A - Amendment
Date filed
9/6/2023, 05:25 PM
Date Of Original Report
Sep 6, 2023
Previous filing
Aug 1, 2023
Next filing
Nov 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GMED Class A Common Stock Award +15.6K 15.6K Sep 1, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GMED Stock Option (Right to Buy Class A Common Stock) Award $0 +15K $0.00 15K Sep 1, 2023 Class A Common Stock 15K $54.23 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pursuant to the Agreement and Plan of Merger, dated as of February 8, 2023 (the "Merger Agreement"), by and among the Issuer, NuVasive, Inc. ("NuVasive") and Zebra Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into NuVasive (the "Merger"), with NuVasive continuing as a wholly owned subsidiary of the Issuer. At the effective time of the Merger, each NuVasive restricted stock unit award was accelerated, cancelled and converted automatically into the right to receive 0.75 shares of Class A common stock of Issuer, par value $0.001 per share, and cash in lieu of fractional shares, in respect of each share of NuVasive common stock underlying such award.
F2 These options were granted on September 1, 2023, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on September 1, 2024, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
F3 The original Form 4, filed on September 6, 2023, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported an expiration date of September 1, 2024, when in fact such expiration date is September 1, 2033.